Raffa Wealth Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38 Hold
4
– – ﹤0.01% 1559
2026
Q2
$35 Buy
+4
New +$30 ﹤0.01% 1543

Other funds holding IBRX

Raffa Wealth Management's IBRX Position: Q3 2026 in Review

Raffa Wealth Management held its ImmunityBio (IBRX) position steady in Q3 2026 at 4 shares worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #1559.

Raffa Wealth Management first reported a position in IBRX in Q2 2026 and has held it in 2 quarters since. 406 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Raffa Wealth Management held 4 shares of ImmunityBio worth $38 as of Q3 2026.
  • Raffa Wealth Management left its ImmunityBio share count unchanged in Q3 2026.
  • ImmunityBio made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1559 holding.
  • Raffa Wealth Management first reported a position in ImmunityBio in Q2 2026 and has held it in 2 quarters since.
  • 406 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.